John Eckman

All articles by John Eckman

Needle Biopsy Underused in Breast Cancer

Gastrointestinal Cancers

Circulating Tumor DNA May Accurately Predict Recurrence of Colon Cancer

By

Jonathan Goodman, MPhil

July 7, 2016

A well-timed, sensitive liquid biopsy could effectively predict post-surgical recurrence of stage 2 colon cancer.

Specific doses of radiation and anthracycline use were linked to increased cardiovascular risk in su

Bendamustine, Gemcitabine, Vinorelbine Promising Treatment for Relapsed or Refractory Hodgkin Lymphoma

By

Jonathan Goodman, MPhil

July 6, 2016

BeGEV appears to provide clinical benefit for patients with relapsed or refractory Hodgkin lymphoma, and ought to be developed further.

Researchers argue that immune therapies that target hormone-receptor-positive breast cancer is not t

Gastrointestinal Cancers

Xilonix Promising for Patients With Advanced or Refractory Colorectal Cancer

By

Jonathan Goodman, MPhil

July 5, 2016

This novel therapy is promising for patients with advanced colorectal cancer, and an examination of a patient’s “health status,” understood as observable symptoms relating to disease, ought to be considered a measure of treatment efficacy for patients in this disease group.

Patients with chronic myeloid leukemia in chronic phase and renal or liver impairment can safely rec

Hematologic Cancers

Rituximab Maintenance Therapy Promising for Patients With Pre-treated CLL

By

Jonathan Goodman, MPhil

July 1, 2016

Maintenance therapy with the monoclonal antibody, rituximab, may improve progression-free survival for patients with chronic lymphocytic leukemia (CLL).

Patients with the allele may metabolize chemotherapy drugs differently, resulting in poorer outcomes

General Oncology

Genomic Data Commons More Than Doubles Number of Genomic Profiles With New Sharing Agreement

By

Jonathan Goodman, MPhil

June 30, 2016

A new data sharing agreement promises major advances in the developing area of personalized medicine.

CTA asked Dr. Patnaik about the evolving understanding of CMML’s molecular underpinnings, diagnosis,

Droplet Digital PCR Promising for Detecting Recurrent Ewing Sarcoma

By

Jonathan Goodman, MPhil

June 29, 2016

A droplet digital polymerase chain reaction (PCR) technique shows promise for predicting recurrence of Ewing sarcoma in specific patients.

As a clinician, your responsibility is to find out what the patient is actually asking, and to provi

General Oncology

Survivors of Adult-onset Cancer Treated With Cisplatin Should Have Routine Auditory Exams

By

Jonathan Goodman, MPhil

June 28, 2016

Survivors of adult-onset cancer who were treated with cisplatin chemotherapy should undergo routine hearing exams.

Clinicians may need to be more proactive in preventing and treating cardiovascular disease in patien

Candesartan Unlikely to Mitigate Cardiac Events in Patients With Early Breast Cancer Undergoing Treatment

By

Jonathan Goodman, MPhil

June 27, 2016

Candesartan is unlikely to mitigate cardiotoxic effects of trastuzumab for patients with early breast cancer.

KRAS is commonly mutated in non-small cell lung cancer (NSCLC), but targeting KRAS directly has been

Patients With Hodgkin Lymphoma May Benefit From PET-CT Scans to Guide Treatment

By

Jonathan Goodman, MPhil

June 24, 2016

Patients with advanced Hodgkin lymphoma may benefit from positron-emission tomography-computed tomography (PET-CT) testing.

A phase 3 trial revealed that the HER2-enriched molecular subtype of breast cancer is more responsiv

Gastrointestinal Cancers

Sugar-sweetened Beverages Linked to Biliary Tract Cancers

By

Jonathan Goodman, MPhil

June 23, 2016

Sugary beverages may raise one’s risk of contracting gallbladder and other varieties of biliary tract cancers (BTCs).

Next post in Gastrointestinal Cancers

Cetuximab substantially improves outcomes in patients with metastatic colorectal cancer with FCGR2A

Biomarker Identifies mCRC Patients Likely to Respond to Cetuximab